Table 3 Clinical pathological parameters for RCC patients after univariate and multivariate analyses
Characteristics | Total (N) | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|---|
Hazard ratio (95% CI) | p value | Hazard ratio (95% CI) | p value | ||
T stage | 539 | ||||
T1 | 278 | Reference | |||
T2 | 71 | 1.515 (0.908–2.526) | 0.112 | 0.177 (0.035–0.903) | 0.037 |
T3 | 179 | 3.354 (2.373–4.742) | < 0.001 | 0.432 (0.117–1.601) | 0.209 |
T4 | 11 | 10.829 (5.467–21.451) | < 0.001 | 0.446 (0.094–2.122) | 0.311 |
N stage | 257 | ||||
N0 | 241 | Reference | |||
N1 | 16 | 3.453 (1.832–6.508) | < 0.001 | 1.433 (0.492–4.169) | 0.509 |
M stage | 506 | ||||
M0 | 428 | Reference | |||
M1 | 78 | 4.389 (3.212–5.999) | < 0.001 | 0.429 (0.040–4.615) | 0.485 |
Age | 539 | ||||
< = 60 | 269 | Reference | |||
> 60 | 270 | 1.765 (1.298–2.398) | < 0.001 | 1.661 (1.052–2.623) | 0.029 |
Histologic grade | 531 | ||||
G1 | 14 | Reference | |||
G2 | 235 | 7,510,356.751 (0.000-Inf) | 0.994 | 3,980,595.814 (0.000-Inf) | 0.996 |
G3 | 207 | 14,161,426.542 (0.000-Inf) | 0.993 | 6,771,509.761 (0.000-Inf) | 0.996 |
G4 | 75 | 38,204,822.146 (0.000-Inf) | 0.993 | 7,718,630.236 (0.000-Inf) | 0.996 |
Pathologic stage | 536 | ||||
Stage I | 272 | Reference | |||
Stage II | 59 | 1.207 (0.650–2.241) | 0.551 | 4.543 (0.707–29.173) | 0.111 |
Stage III | 123 | 2.705 (1.800–4.064) | < 0.001 | 3.972 (0.986–16.005) | 0.052 |
Stage IV | 82 | 6.692 (4.566–9.808) | < 0.001 | 27.692 (2.086–367.529) | 0.012 |
Gender | 539 | ||||
Female | 186 | Reference | |||
Male | 353 | 0.930 (0.682–1.268) | 0.648 | ||
FDCSP | 539 | ||||
Low | 269 | Reference | |||
High | 270 | 1.809 (1.325–2.468) | < 0.001 | 0.991 (0.621–1.582) | 0.970 |